S

Swedencare AB (publ)
STO:SECARE

Watchlist Manager
Swedencare AB (publ)
STO:SECARE
Watchlist
Price: 37.6 SEK -1.31% Market Closed
Market Cap: 6B SEK

Relative Value

The Relative Value of one SECARE stock under the Base Case scenario is hidden SEK. Compared to the current market price of 37.6 SEK, Swedencare AB (publ) is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SECARE Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
93
vs Industry
46
Median 3Y
2.9
Median 5Y
3.7
Industry
2.6
Forward
2.2
vs History
66
vs Industry
6
Median 3Y
96.7
Median 5Y
131.4
Industry
21.7
Forward
53.8
vs History
79
vs Industry
25
Median 3Y
18.8
Median 5Y
22.1
Industry
16.7
vs History
58
vs Industry
16
Median 3Y
18.8
Median 5Y
20.5
Industry
23.1
vs History
68
vs Industry
66
Median 3Y
0.9
Median 5Y
1.1
Industry
2.2
vs History
92
vs Industry
39
Median 3Y
3.5
Median 5Y
4.4
Industry
2.9
Forward
2.7
vs History
68
vs Industry
27
Median 3Y
8.5
Median 5Y
9.6
Industry
5.5
vs History
79
vs Industry
27
Median 3Y
17
Median 5Y
21.5
Industry
13.2
Forward
14.3
vs History
76
vs Industry
13
Median 3Y
48.5
Median 5Y
64.5
Industry
16.8
Forward
35.2
vs History
79
vs Industry
21
Median 3Y
22.7
Median 5Y
25.8
Industry
15.9
vs History
79
vs Industry
19
Median 3Y
27
Median 5Y
30.9
Industry
19.2
vs History
71
vs Industry
67
Median 3Y
0.8
Median 5Y
1
Industry
1.9

Multiples Across Competitors

SECARE Competitors Multiples
Swedencare AB (publ) Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
Swedencare AB (publ)
STO:SECARE
6B SEK 2.2 95.4 15.7 44.1
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.1 55 36.9 39.6
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
496.6B USD 5.4 19.8 16.2 21
CH
Roche Holding AG
SIX:ROG
259.2B CHF 4.2 27.5 11.7 13.7
UK
AstraZeneca PLC
LSE:AZN
212B GBP 4.9 30.2 108.4 158.6
CH
Novartis AG
SIX:NOVN
208.2B CHF 4.7 18.2 11.5 14.9
US
Merck & Co Inc
NYSE:MRK
251.4B USD 3.9 13.2 9.4 11.2
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.4 13.3 9.3 10.8
IE
Endo International PLC
LSE:0Y5F
209B USD 90.1 -71.5 331.1 830.4
US
Pfizer Inc
NYSE:PFE
143.2B USD 2.3 14.6 7.4 10.2
P/E Multiple
Earnings Growth PEG
SE
S
Swedencare AB (publ)
STO:SECARE
Average P/E: 31.9
95.4
54%
1.8
US
Eli Lilly and Co
NYSE:LLY
55
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.8
29%
0.7
CH
Roche Holding AG
SIX:ROG
27.5
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
30.2
38%
0.8
CH
Novartis AG
SIX:NOVN
18.2
17%
1.1
US
Merck & Co Inc
NYSE:MRK
13.2
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13.3
4%
3.3
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -71.5 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.6
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
SE
S
Swedencare AB (publ)
STO:SECARE
Average EV/EBITDA: 400.4
15.7
16%
1
US
Eli Lilly and Co
NYSE:LLY
36.9
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.2
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.7
4%
2.9
UK
AstraZeneca PLC
LSE:AZN
108.4
10%
10.8
CH
Novartis AG
SIX:NOVN
11.5
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.4
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.3
2%
4.6
IE
E
Endo International PLC
LSE:0Y5F
331.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
1%
7.4
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
SE
S
Swedencare AB (publ)
STO:SECARE
Average EV/EBIT: 1 714.2
44.1
31%
1.4
US
Eli Lilly and Co
NYSE:LLY
39.6
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.7
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
158.6
23%
6.9
CH
Novartis AG
SIX:NOVN
14.9
12%
1.2
US
Merck & Co Inc
NYSE:MRK
11.2
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
10.8
1%
10.8
IE
E
Endo International PLC
LSE:0Y5F
830.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
8%
1.3